Esperion Therapeutics ESPR Pivotal Trial Results Fixed Dose Combination Pill...
On Monday August 27 2018 Esperion investigators presented the pivotal results of the FixedDose Combination FDC pill of bempedoic acid BA ezetimibe EZE trial Study 053; 1002FDC053. It was tested on high...
View ArticleNonStatin Combo Pill for LDL Reduction Shines in Trial
MedPage Today LDL cholesterol down 32 in patients maxed out on statins
View ArticleAmarin Corp Plc AMRN Financial and Strategic SWOT Analysis Review Report...
Amarin Corp Plc AMRN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData...
View ArticleLower Cholesterol Treatment Breakthrough
GORDON Australia Aug. 30 2018 PRNewswire The American offshoot of Australian biotech Noxopharm Nyrada believes it is within reach of achieving a major advance in the treatment of cardiovascular...
View ArticleDaiichi Sankyo Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryDaiichi Sankyo Inc Daiichi Sankyo a subsidiary of Daiichi Sankyo Company Ltd is a healthcare products provider that discovers and develops medicines for cardiovascular and metabolic disorders....
View ArticlePromising new drug candidate designed to lower cholesterol
The American offshoot of Australian biotech Noxopharm Nyrada is reporting important progress with a drug candidate known as NYX330 believed by the company to be the next breakthrough medication for...
View ArticleEvidence Doesn't Support Statin Use in Healthy Seniors
THURSDAY Sept. 6 2018 There is no evidence to support the widespread use of cholesterollowering statin drugs to prevent heart disease and stroke in old and very old people Spanish researchers say.For...
View ArticleWidespread Statin Use Not Recommended in Old Very Old
THURSDAY Sept. 6 2018 Statin use is not associated with reduced risk of atherosclerotic cardiovascular disease CVD or allcause mortality among older adults without type 2 diabetes according to a study...
View ArticleFDA to review supplemental Biologics License Application for PraluentÂ...
FDA to review supplemental Biologics License Application for Praluent alirocumab Injection as potential treatment to reduce major adverse cardiovascular events FDA also recently approved Praluent...
View ArticlePaying People To Lower Their Cholesterol Works But Is It CostEffective
Offering financial rewards to patients who lower their bad cholesterol by adhering to statin regimens could help prevent heart disease but there are lingering questions about whether such a strategy is...
View ArticleStatin Benefits After 75 Limited to Patients With Diabetes
Analysis of NHANES data showed no overall benefit of statins for primary prevention with the exception of adults with type 2 diabetes and only for those aged 75 to 84 years. Medscape Medical News
View ArticleStatins Improve LongTerm Survival After AAA Repair
THURSDAY Sept. 20 2018 Preoperative statin therapy is associated with higher longterm survival following abdominal aortic aneurysm AAA repair according to a study published in the August issue of the...
View ArticleStatin Use in Advanced CKD Lowers Death Risk
Researchers report a significant 41 decreased mortality risk among patients with advanced CKD who used statins compared with those who did not.
View ArticleCV Risk in Hypertriglyceridemic Patients With LDLC Control
Elevated triglyceride levels may contribute to a greater risk for cardiovascular disease despite statincontrolled LDL cholesterol levels. Journal of Clinical Endocrinology & Metabolism
View ArticleVascepa's big heart benefit pumps up Amarin's value by $2B
Amarin&39;s CEO called it "the single most significant advance in preventative cardiovascular drug therapy since the advent of statin therapy."
View ArticleOmega3 Pill Prevents CV Events in HighRisk Patients
The omega3 pill Vascepa icosapent ethyl approved to treat very high triglyceride levels significantly lowered the risk for cardiovascular events in statintreated patients...
View ArticleAdvances in Breast and Gastric Cancer Research Presented for the First Time...
Groundbreaking research in the field of cancer imaging was presented at the 2018 World Molecular Imaging Congress WMIC September 1215 in Seattle WA USA.CULVER CITY Calif. PRWEB September 26 2018...
View ArticleTCT.18 PrePCI statin dose slashes MACE by 28
Acute coronary syndrome patients who were given a loading dose of atorvastatin before percutaneous coronary intervention PCI experienced a 28 percent reduction in major adverse cardiovascular events...
View ArticleStatins Fibrates Lower Diabetic Retinopathy Risks in Diabetes
Patients with type 2 diabetes given statin or fibrate lipidlowering therapy have both a reduced risk of developing diabetic retinopathy and being treated for the condition Japanese claims data show....
View Article